Aker BioMarine

M&A Activity • Feb 14, 2024

Aker BioMarine ASA – Initiating a strategic review for the “Feed Ingredients” business unit

Aker BioMarine ASA – Initiating a strategic review for the “Feed Ingredients” business unit

On 29 June 2023, Aker BioMarine ASA (“Aker BioMarine” or the “Company”) announced a change to its group financial reporting and legal entity structure, separating into business units (1) Feed Ingredients; (2) Human Health Ingredients; (3) Consumer Health Ingredients; and (4) Emerging Businesses. As of 1 January 2024, the financial and legal reorganization has been completed and the business units are now operational as separate business units.

Based on external interest for the Feed Ingredients business, the Company has decided to initiate a process to explore strategic alternatives for that business unit.

Aker BioMarine Feed Ingredients is the world’s largest krill harvester and producer of krill meal. Krill meal is a premium marine ingredient used in aquaculture feed, pet food and for extraction of krill oil for human consumption. Feed Ingredients owns and operates three specialized harvesting vessels and a support vessel. Production takes place in Antarctica utilizing an efficient and sustainable harvesting technology.

Feed Ingredients has experienced strong growth over the recent years and realized FY23 adjusted revenues of approximately USD 156 million and an adjusted cash EBITDA of approximately USD 49 million, with a current run rate cash EBITDA at USD 57 million. See further details in the Q4 2023 presentation.

To assist Aker BioMarine in this process, the Company has engaged Arctic Securities, Carnegie and Rabobank as financial advisers.

For further information, please contact

Christopher Robin Vinter, VP IR & Corporate Finance

Mobile: +47 911 60 820

Email: Christopher.vinter@akerbiomarine.com

About Aker BioMarine

Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act and contains information deemed to constitute inside information pursuant to the European Market Abuse Regulation. This announcement was published by Christopher Robin Vinter, VP IR & Corporate Finance of Aker BioMarine ASA on 14 February 2024.